相关实验视频
Updated: Jul 9, 2025
09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.4K
纤维性疾病中的微RNA:未来治疗方法的潜在目标
Aanushka Mehjabin1, Maliha Kabir1, Luigina Micolucci2
1Science and Math Program, Asian University for Women, 4000 Chattogram, Bangladesh.
Frontiers in bioscience (Landmark edition)
|December 8, 2023
概括
纤维化疾病涉及过度组织痕由于细胞外矩阵的积累. 微RNAs (miRNAs) 正在成为治疗这些渐进性纤维性疾病的关键治疗点.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 纤维性疾病的特征是细胞外基质 (ECM) 沉积过多,导致器官痕和功能障碍.
- 由于治疗选择有限,这些渐进性疾病给医疗保健带来了重大挑战.
- 微RNAs (miRNAs) 是小型非编码RNAs,它们调节基因表达,并在纤维化过程中发挥关键作用.
研究的目的:
- 审查miRNAs在各种纤维性疾病中的作用.
- 讨论最近基于miRNA的纤维化治疗策略的进展.
主要方法:
- 关于miRNAs和纤维性疾病研究的文献综述.
- 对miRNA参与纤维细胞激活和ECM重塑的分析.
- 检查针对miRNAs的治疗方法.
主要成果:
- MiRNAs与心脏,肝脏,脏,肺部,皮肤纤维化和原发性髓纤维化病原发生有关.
- 针对特定的miRNAs提供了一个有前途的治疗途径.
- 目前正在探索各种策略,包括反感性寡核酸和小分子调节器.
结论:
- 米RNAs是纤维性疾病的关键调节者.
- 基于MiRNA的治疗方法代表了对抗纤维化的新和不断发展的方法.
- 进一步的研究有可能开发有效的纤维菌疾病治疗方法.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:24Cystic Fibrosis: Management
170
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
170